First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study
by D'Angelo, Sandra P. (Author)
, Lebbé, C. (Author)
, Mortier, L. (Author)
, Brohl, A. S. (Author)
, Fazio, N. (Author)
, Grob, J. -J. (Author)
, Prinzi, N. (Author)
, Hanna, G. J. (Author)
, Hassel, Jessica C. (Author)
, Kiecker, F. (Author)
, von Heydebreck, A. (Author)
, Güzel, G. (Author)
, Nghiem, P. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource